Leptin as a mediator between obesity and cardiac dysfunction
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
Obesity is now recognised as one of the most important risk factors for heart disease. Obese individuals have high circulating levels of leptin, a hormone secreted by adipose tissue and involved in energy homeostasis. Growing evidence suggests that leptin may contribute to the development of cardiac dysfunction. In a large prospective study leptin has been shown to be an independent risk factor for coronary heart disease. An independent positive association has also been found between plasma leptin levels and heart rate in hypertensive patients and heart transplant recipients. In animal studies chronic leptin infusion increased heart rate and blood pressure. It has also been demonstrated that circulating leptin levels are elevated in patients with heart failure. The level of plasma leptin was associated with increased myocardial wall thickness and correlated with left ventricular mass, suggesting a role for this hormone in mediating left ventricular hypertrophy in humans. Moreover, leptin directly induced hypertrophy and hyperplasia in human and rodent cardiomyocytes, accompanied by cardiac extracellular matrix remodelling. Leptin may also influence energy substrate utilisation in cardiac tissue. These findings suggest that leptin acting directly or through the sympathetic nervous system may have adverse effects on cardiac structure and function, and that chronic hyperleptinaemia may greatly increase the risk of cardiac disorders. Additional studies are needed to define the role of leptin in cardiac physiology and pathophysiology, nevertheless the reduction in plasma leptin levels with caloric restriction and weight loss may prevent cardiac dysfunction in obese patients.
Authors and Affiliations
Joanna Karbowska, Zdzisław Kochan
Keywords
Related Articles
- EP ID EP66687
- DOI -
- Views 173
- Downloads 0
Znaczenie badań farmakogenetycznych w efektywności leczenia metotreksatem chorych na reumatoidalne zapalenie stawów (część 2)
Obecnie dużą nadzieję wiąże się z indywidualizacją leczenia chorych na reumatoidalne zapalenie stawów (RZS). Trwają poszukiwania markerów biochemicznych i klinicznych, dzięki którym można by przewidzieć dobrą odpowiedź...
Blocking of α1β1 and α2β1 adhesion molecules inhibits eosinophil migration through human lung microvascular endothelial cell monolayer
In cell trafficking to the airways in asthma, among integrins the most important are those containing α4 and β2 subunits. We have previously shown that also blocking of collagen receptors, α1β1 and α2β1 integrins, inhibi...
Czy mutacje w genie kodującym czynnik transkrypcyjny EKLF (Erythroid Krüppel-Like Factor) mogą chronić nas przed chorobami zakaźnymi i pasożytniczymi?
Czynnik transkrypcyjny EKLF (Erythroid Krüppel-Like Factor) należy do grupy czynników Krüppel-podobnych, które regulują proliferację, różnicowanie, rozwój i apoptozę komórek w organizmach ssaków. Czynnik EKLF występuje w...
Short-term exposure to ambient fine particulate matter (PM2,5 and PM10) and the risk of heart rhythm abnormalities and stroke
Results of epidemiological studies suggest a significant impact of ambient particulate matter air pollution (PM10 and PM2,5) on the health of the population. Increased level of these pollutants is connected with increase...
Oporność Pseudomonas aeruginosa na antybiotyki
Największym problemem w leczeniu zakażeń szpitalnych jest narastająca lekooporność, wywołujących je drobnoustrojów, ograniczająca liczbę skutecznych antybiotyków. Pałeczki Pseudomonas aeruginosa są przyczyną wielu groźny...